Charles B. O'Keeffe Net Worth & Insider Trades

Charles B. O'Keeffe - Director, Catalyst Pharmaceuticals, Inc

As of November 17, 2022

What is Charles B. O'Keeffe's Net Worth?

The current estimated net worth of Catalyst Pharmaceuticals, Inc's Director, Charles B. O'Keeffe, is estimated to be about $3.99M . Charles B. O'Keeffe owns about 565,057 units of Catalyst Pharmaceuticals, Inc common stock. In the last 15 years at Catalyst Pharmaceuticals, Inc, Charles B. O'Keeffe has sold an estimated value of $0 worth.

What is Charles B. O'Keeffe's Past Insider Trading?

Charles B. O'Keeffe's largest purchase order was 87,985 units , worth over $1.41M on November 17, 2022. In total, Charles B. O'Keeffe has made about 59 transactions over 15 years of their time at Catalyst Pharmaceuticals, Inc. Charles B. O'Keeffe usually trades in December and November, with the busiest year in 2016 and 2015.

Charles B. O'Keeffe

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Charles B. O'Keeffe's' Mailing Address?

  • Mailing address is 220 Miracle Mile Suite 234 Coral Gables FL 33134 FL

Catalyst Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Patrick J. McEnany 2018 $524,236 $332,063 $ $3,461,504 $3,461,504 $ $3,461,504
Steven R. Miller, COO and CSO 2018 $427,441409,325 $188,600 $ $1,655,195 $1,655,195 $11,000 $1,655,195
Gary Ingenito, CM&RO 2018 $399,373 $194,810 $ $1,666,645 $1,666,645 $26,192 $1,666,645
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1369568/000119312520188818/d932120ddef14a.htm

What are Catalyst Pharmaceuticals, Inc's Past Insider Trades?

Catalyst Pharmaceuticals, Inc's most recent insider trade came on November 23, 2022 by Alicia Grande who sold 120,000 units worth $1.98M . In the last 15 years, insiders at Catalyst Pharmaceuticals, Inc have sold an estimated value of $56.83M and bought an estimated value of $19.06M worth of shares. Insider trading is most common in December, with the busiest year in 2022. The most active traders at the company are Patrick J McEnany, President and CEO,  Charles B. O'Keeffe, Director,  and Philip H Coelho, Director .

CATALYST PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1